Cargando…

Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets

Diabetes and obesity have reached an epidemic status worldwide. Diabetes increases the risk for cardiovascular disease and non-alcoholic fatty liver disease. Primary bile acids are synthesized in hepatocytes and are transformed to secondary bile acids in the intestine by gut bacteria. Bile acids are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrell, Jessica M., Chiang, John Y. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581552/ https://www.ncbi.nlm.nih.gov/pubmed/31210034 http://dx.doi.org/10.4093/dmj.2019.0043

Ejemplares similares

Short-Term Circadian Disruption Impairs Bile Acid and Lipid Homeostasis in Mice
por: Ferrell, Jessica M., et al.
Publicado: (2015)

Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy
por: Chiang, John Y. L., et al.
Publicado: (2020)

Recent advances in understanding bile acid homeostasis
por: Chiang, John YL
Publicado: (2017)

Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis
por: Chiang, John Y.L., et al.
Publicado: (2020)

Bile Acid Signaling in Liver Metabolism and Diseases
por: Li, Tiangang, et al.
Publicado: (2012)

Pathophysiology and Clinical Management of Bile Acid Diarrhea
por: Marasco, Giovanni, et al.
Publicado: (2022)

Targeting bile acids and lipotoxicity for NASH treatment
por: Chiang, John Y. L.
Publicado: (2017)

Deficiency of cholesterol 7α‐hydroxylase in bile acid synthesis exacerbates alcohol‐induced liver injury in mice
por: Donepudi, Ajay C., et al.
Publicado: (2017)

The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids
por: Sagar, Nidhi M., et al.
Publicado: (2020)

Regulation of Bile Acid and Cholesterol Metabolism by PPARs
por: Li, Tiangang, et al.
Publicado: (2009)

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
por: Toth-Manikowski, Stephanie, et al.
Publicado: (2015)

Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
por: Bertolini, Anna, et al.
Publicado: (2022)

Bile acid diarrhoea: pathophysiology, diagnosis and management
por: Farrugia, Alexia, et al.
Publicado: (2020)

Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets
por: Nian, Shen, et al.
Publicado: (2021)

Therapeutic Roles of Bile Acid Signaling in Chronic Liver Diseases
por: Li, Yan, et al.
Publicado: (2018)

Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
por: Long, Xiong-Quan, et al.
Publicado: (2023)

PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
por: Altalhi, Rawan, et al.
Publicado: (2021)

Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart
por: Hanafi, Noorul Izzati, et al.
Publicado: (2018)

Coronary “Microvascular Dysfunction”: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics
por: Kei, Chun Yeung, et al.
Publicado: (2023)

My lifelong dedication to bile acid research
por: Chiang, John Y.L.
Publicado: (2023)

Interactive Relationships between Intestinal Flora and Bile Acids
por: Guo, Xiaohua, et al.
Publicado: (2022)

Targeting the gut microbiota for treating colitis: Is FGF19 a magic bullet?
por: Chiang, John Y.L., et al.
Publicado: (2020)

Bile acid signaling and biliary functions
por: Jones, Hannah, et al.
Publicado: (2015)

Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis
por: Simbrunner, Benedikt, et al.
Publicado: (2021)

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
por: Lin, Chuan-Hao, et al.
Publicado: (2018)

Circadian rhythms in liver metabolism and disease
por: Ferrell, Jessica M., et al.
Publicado: (2015)

Impact of critical illness on cholesterol and fatty acids: insights into pathophysiology and therapeutic targets
por: Lauwers, Caroline, et al.
Publicado: (2023)

Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review)
por: Luo, Wenyu, et al.
Publicado: (2022)

Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets
por: Li, Yading, et al.
Publicado: (2021)

Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets
por: Sagar, Rebecca C., et al.
Publicado: (2022)

XXIII international bile acid meeting: Bile acids as signal integrators and metabolic modulators
por: Eapen, C. E.
Publicado: (2017)

Inner ear symptoms and disease: Pathophysiological understanding and therapeutic options
por: Ciuman, Raphael R.
Publicado: (2013)

Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies
por: Salekeen, Rahagir, et al.
Publicado: (2022)

The Biosynthesis, Signaling, and Neurological Functions of Bile Acids
por: Kiriyama, Yoshimitsu, et al.
Publicado: (2019)

Bile Acid Signaling in Neurodegenerative and Neurological Disorders
por: Grant, Stephanie M., et al.
Publicado: (2020)

Bile Acid Signaling in Inflammatory Bowel Disease
por: Bromke, Mariusz A., et al.
Publicado: (2021)

Overview of bile acid signaling in the cardiovascular system
por: Zhang, Rou, et al.
Publicado: (2021)

Bile Acids: Key Regulators and Novel Treatment Targets for Type 2 Diabetes
por: Wu, Yingjie, et al.
Publicado: (2020)

Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets
por: Tian, Changhai, et al.
Publicado: (2023)

Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options
por: Abu-Zeinah, Ghaith, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ae772q6818l4sphpqprfn1ruh9